The DC CFAR Pilot Awards Program aims to provide pilot funds on a competitive basis to HIV/AIDS investigators to assist them in the development of their NIH-funded research careers.
Faculty investigators at eight participating DC CFAR institutions (American University, Children's National Health System, DC Health, Georgetown University, George Washington University, Howard University, Veterans Affairs Medical Center, and Whitman-Walker) who are full members of the DC CFAR are eligible to apply as Principal Investigators (PI) to the program.
These funds are provided to support early stage and new HIV/AIDS investigators, with an emphasis on women and underrepresented minorities. Principal Investigators must have a terminal degree and be eligible to submit NIH grant applications through their home institution’s office of research. PIs must be at the rank of Assistant Professor, Associate Professor, Full Professor or Research Scientist. New investigators are those who have not previously served as the PI on an HIV/AIDS-related R01 NIH award or equivalent, including R23, R29, R37, and DP2 (for more information, please visit the NIH guidance on investigator types). Clinical and post-doctoral fellows are not eligible to apply as PIs.
The Pilot Awards fund research projects that focus on HIV/AIDS and related opportunistic illnesses. The scope of funded projects includes basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science. Applications should focus on the NIH high priority HIV/AIDS research areas, which broadly focus on: reducing HIV/AIDS incidence; the next generation of HIV therapies and implementation research on the HIV continuum of care; cure research; HIV-associated comorbidities, coinfections, and complications; and cross cutting areas in basic research and health disparities. Special consideration will be given to applications in the focus areas of the DC CFAR Scientific Working Groups (SWGs) in HIV Cure research and Ending the HIV epidemic and Scientific Interest Groups (SIGs) in Drug User Health, Women and HIV, Aging and Comorbidities, Latina/x/o, Global, and Sexual and Gender Minorities. Applicants are strongly encouraged to contact the relevant SWG and/or SIG leaders to explore possible mentorship or collaboration on their proposals. Collaborations are strongly encouraged with other large NIH-funded HIV studies in DC including the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort Study (MACS/WIHS CCS) and the DC Cohort. Investigators interested in exploring such collaborations should contact Ms. Brandi Robinson, who will facilitate connectivity to these projects. Investigators will be required to consult with the leaders of the MACS/WIHS CCS and DC Cohort to assess what is feasible/available. If use of these cohorts is deemed feasible, approved concept sheets and letters of support from the cohorts must be submitted in the full pilot award application. Although it is not required that the project take place in Washington, DC, investigators should be prepared to demonstrate how their research project relates to, and could impact, the HIV/AIDS epidemic in the District of Columbia.
For examples of these projects, please review the abstracts of previously funded projects.
Each year there are between one and three award cycles. Each cycle may vary slightly in terms of eligibility and scope of solicited proposals. Review the request for applications (PDF) and all application materials before completing the Pre-Submission Form.
- Pilot Awards Program
- NIH CFAR Administrative Supplements
- Transitioning Investigator Awards Program
- Rapid Response Research Awards on COVID-19 and HIV
- Rapid Response Research Awards on the MPX-HIV Interface
- Acknowledge Funding and Services
District of Columbia Center for AIDS Research
Supported by the following Co-Funding and Participating Institutes: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. (P30AI117970)